⌘K

Login Start Free

Home/Filings/4/0000943819-25-000183

4//SEC Filing

Farrell Michael J. 4

Accession 0000943819-25-000183

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 3:29 PM ET

Size

6.0 KB

Accession

0000943819-25-000183

Insider Transaction Report

Form 4

Period: 2025-11-24

Farrell Michael J.

DirectorChairman and CEO

Transactions

Award
ResMed Common Stock Options
2025-11-24$250.52/sh+33,288$8,339,310→ 33,288 total
Exercise: $250.52From: 2026-11-11Exp: 2032-11-11→ ResMed Common Stock (33,288 underlying)

Holdings

ResMed Common Stock
466,223

Footnotes (1)

[F1]Represents the date on which options first become exercisable. The options vest in three equal annual installments commencing on November 11, 2026.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001485164

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 3:29 PM ET
Size: 6.0 KB

View on SEC.gov